Company
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
432 Legal Matters
67
365
0
JANSSEN PHARMACEUTICALS (Johnson & Johnson) Company IP Overview
Recent StatisticsView All
PatentsView All
Patents Issued Each Year
NewsView All
Knobbe Martens
•
Knobbe Martens
•
Dec 4, 2017
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar,(1) ... Read More
PatentsView All
Patents Issued Each Year
Recent StatisticsView All
NewsView All
Knobbe Martens
•
Knobbe Martens
•
Dec 4, 2017
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar,(1) ... Read More